Locations:
SearchAdvertisement
Community-based data help predict patients’ response to immune checkpoint inhibitors
Regional differences appear to have no bearing on how patients fare
New findings may lead to less-toxic tumor therapies
Common cancer therapy increases serious risks in murine models
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study suggests new approach is safer than standard treatment and may help prevent graft-versus-host disease
Understudied Src Family Kinase may serve as a potential therapeutic target
Sarcopenia and sarcopenic obesity appear to increase risk of early chemotherapy termination
Study associates human CD38-targeting antibody with fewer complications
Forecasting tool outperforms individual biomarkers
Retired-protein strategy represents new approach to immunization
Advertisement
Advertisement